Clinical Trial Update: Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating intra-gastric injection of Botulinum Toxin A for obesity/weight loss in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Tan Tock Seng Hospital | Conditions: Obesity, Weight Loss | Phase 2, Phase 3 | Status: UNKNOWN